Electronic medication monitoring versus self-reported use of inhaled corticosteroids and short-acting beta2-agonists in uncontrolled asthma.
Giselle S MosnaimDavid A StempelCandy GonzalezBrittney AdamsNaomi BenIsrael-OliveRahul GondaliaLeanne KayeMadeleine ShalowitzStanley J SzeflerPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2021)
Significant discrepancies between self-report and objective ICS usage were observed. EMM can provide clinicians with accurate data on ICS medication taking behavior, thus reducing medication regimen complexity, side effects, and costs.